Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P. Feb 17, 2026 04:41PM
Form SCHEDULE 13G PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P. Oct 9, 2025 04:28PM
Palisade Bio closes $138 million public offering to fund drug trial Oct 2, 2025 04:05PM
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option Oct 2, 2025 04:05PM